Articles

In response to user feedback, we have been trialling a beta version of the DAEN – medicines since June 2022 alongside the older database.

This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Medicines Safety Update - Information for health professionals

The TGA has issued a direction notice to a Melbourne-based individual to cease advertising of all nicotine vaping products.

The TGA has today published an interim decision to reduce the maximum pack sizes for various paracetamol products.

From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.

The TGA has issued infringement notices to Caveman Nutrition Pty Ltd, The Cave Nutrition Store Pty Ltd and to the director of these companies for the alleged unlawful advertising of sports supplements and therapeutic goods not included in the ARTG.

The TGA has issued an infringement notice totalling $13,320 to Sydney company JSHealth Vitamins Pty Ltd for supplying a complementary medicine that allegedly did not conform with legal requirements.

This instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.

The TGA has confirmed the performance of COVID-19 rapid antigen tests available on the Australian market with COVID-19 variants.

New guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.

Medicines Safety Update - Information for health professionals

The TGA has issued infringement notices to Mode Medical Pty Ltd for the alleged unlawful advertising to Australian consumers on a company website and social media.

Information about the TGA's safety monitoring of COVID-19 vaccines.

This is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.

The TGA has commenced evaluation of an application from Moderna Australia Pty Ltd to transition its COVID-19 vaccine, SPIKEVAX, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Current antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.

Information about the TGA's safety monitoring of COVID-19 vaccines.

Medicines Safety Update - Information for health professionals

The Prescribing Medicines in Pregnancy database has now been updated.

The Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.

Travellers will be able to bring up to 3-months supply of their medicine.

Approval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations)